BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Metz DK, Holford N, Kausman JY, Walker A, Cranswick N, Staatz CE, Barraclough KA, Ierino F. Optimizing Mycophenolic Acid Exposure in Kidney Transplant Recipients: Time for Target Concentration Intervention. Transplantation 2019;103:2012-30. [PMID: 31584924 DOI: 10.1097/TP.0000000000002762] [Cited by in Crossref: 15] [Cited by in F6Publishing: 3] [Article Influence: 7.5] [Reference Citation Analysis]
Number Citing Articles
1 Hao XS, Wang JT, Chen C, Hao YP, Liang JM, Liu SY. Effectiveness of Mycophenolate Mofetil in the Treatment of Pediatric Anti-NMDAR Encephalitis: A Retrospective Analysis of 6 Cases. Front Neurol 2020;11:584446. [PMID: 33240207 DOI: 10.3389/fneur.2020.584446] [Reference Citation Analysis]
2 Gabardi S. Immunosuppression in the Age of Precision Medicine. Seminars in Nephrology 2022;42:86-98. [DOI: 10.1016/j.semnephrol.2022.01.001] [Reference Citation Analysis]
3 Mohammadi K, Yaribash S, Razi B, Dashti-Khavidaki S. Comparing safety of proton-pump inhibitors versus H2-receptor antagonists in kidney transplant recipients: A systematic review and meta-analysis. J Clin Pharm Ther 2021. [PMID: 34931328 DOI: 10.1111/jcpt.13589] [Reference Citation Analysis]
4 Nourbakhsh N, Ekberg J, Skov K, Peters CD, Øzbay A, Lindner P, Buus NH. Effects of Corticosteroid Treatment on Mycophenolic Acid Exposure in Renal Transplant Patients-Results From the SAILOR Study. Front Pharmacol 2021;12:742444. [PMID: 34594229 DOI: 10.3389/fphar.2021.742444] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Na Takuathung M, Sakuludomkan W, Koonrungsesomboon N. The Impact of Genetic Polymorphisms on the Pharmacokinetics and Pharmacodynamics of Mycophenolic Acid: Systematic Review and Meta-analysis. Clin Pharmacokinet 2021. [PMID: 34105062 DOI: 10.1007/s40262-021-01037-7] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
6 Liu Y, Zhang H, Li J, Liu L, Wu C, Fu Q, Huang M, Chen X, Wang C, Chen P. Pharmacokinetics of free and total mycophenolic acid in paediatric and adult renal transplant recipients: Exploratory analysis of the effects of clinical factors and gene variants. Basic Clin Pharmacol Toxicol 2022;131:60-73. [PMID: 35567285 DOI: 10.1111/bcpt.13743] [Reference Citation Analysis]
7 Riglet F, Bertrand J, Barrail-Tran A, Verstuyft C, Michelon H, Benech H, Durrbach A, Furlan V, Barau C. Population Pharmacokinetic Model of Plasma and Cellular Mycophenolic Acid in Kidney Transplant Patients from the CIMTRE Study. Drugs R D 2020;20:331-42. [PMID: 33025511 DOI: 10.1007/s40268-020-00319-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
8 Cossart AR, Staatz CE, Gorham G, Barraclough KA. Comparison of free plasma versus saliva mycophenolic acid exposure following mycophenolate mofetil administration in adult kidney transplant recipients. Clin Biochem 2021:S0009-9120(21)00307-6. [PMID: 34800491 DOI: 10.1016/j.clinbiochem.2021.11.008] [Reference Citation Analysis]
9 Barraclough KA, Metz D, Staatz CE, Gorham G, Carroll R, Majoni SW, Cherian S, Swaminathan R, Holford N. Important lack of difference in tacrolimus and mycophenolic acid pharmacokinetics between Aboriginal and Caucasian kidney transplant recipients. Nephrology (Carlton) 2022. [PMID: 35727904 DOI: 10.1111/nep.14080] [Reference Citation Analysis]
10 Quinlan C. The Future of Paediatric Nephrology—Genomics and Personalised Precision Medicine. Curr Pediatr Rep 2020;8:115-21. [DOI: 10.1007/s40124-020-00218-5] [Reference Citation Analysis]
11 Dave V, Polkinghorne KR, Leong KG, Kanellis J, Mulley WR. Initial mycophenolate dose in tacrolimus treated renal transplant recipients, a cohort study comparing leukopaenia, rejection and long-term graft function. Sci Rep 2020;10:19379. [PMID: 33168923 DOI: 10.1038/s41598-020-76379-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
12 Udomkarnjananun S, Francke MI, De Winter BCM, Mulder MB, Baan CC, Metselaar HJ, den Hoed CM, Hesselink DA. Therapeutic drug monitoring of immunosuppressive drugs in hepatology and gastroenterology. Best Pract Res Clin Gastroenterol 2021;54-55:101756. [PMID: 34874840 DOI: 10.1016/j.bpg.2021.101756] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]